News

St John of God Bendigo now providing L-Dex to Breast cancer patients

St John of God Bendigo Hospital is now able to identify early stages of lymphoedema in patients at risk of developing the condition from breast cancer treatment, thanks to the Valkyrie Groups generous donation.

12 Oct 2017

St John of God Bendigo Hospital breast care nurse Rosemary Gillies

12 October 2017

The machine is called a Bioimpedence machine or L-DexU400. It is a measurement system used to aid the assessment of lymphoedema of the arm. It also enables a series of measurements to be done to assess for effectiveness of therapy for those who already have lymphoedema.

Lymphoedema is a condition that can cause significant swelling of the arm due to extracellular fluid build-up.

"This can occur when the lymphatic system, responsible for draining excess fluid is compromised due to breast cancer therapies. Using this device we are able to detect changes early and enable early therapeutic treatment. Early detection is critical to aid successful management of the condition," says St John of God Bendigo Hospital McGrath Breast Care Nurse Rosie Gillies.

"This procedure is a standard of best practice, used worldwide, as it can detect very early changes in fluid levels and enable preventative therapeutic treatment to be initiated.

"It’s a non-invasive measurement system making a huge difference in the detection and treatment process for patients.

"The Valkyrie group kindly donated $6500 towards the purchase of the L-Dex U400. This is going to make a big difference to the lives of St John of God patients undergoing breast cancer treatment."